Belarusian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
chymotrypsin/запаленне
Спасылка захоўваецца ў буферы абмену
Старонка 1 ад 19 вынікі
Substituted isocoumarins as serine protease inhibitors and anti-inflammatory agents
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a novel class of heterocyclic compounds useful for selectively inhibiting trypsin-like enzymes, selectively inhibiting chymotrypsin-like enzymes, selectively inhibiting elastase or for generally inhibiting serine
Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a novel class of heterocyclic compounds useful for selectively inhibiting trypsin-like enzymes, selectively inhibiting chymotrypsin-like enzymes, selectively inhibiting elastase or for generally inhibiting serine
Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a novel class of heterocyclic compounds useful for selectively inhibiting trypsin-like enzymes, selectively inhibiting chymotrypsin-like enzymes, selectively inhibiting elastase or for generally inhibiting serine
Compounds for enzyme inhibition
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
TECHNICAL FIELD
This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition.
BACKGROUND OF THE INVENTION
In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in
Compounds for enzyme inhibition
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
TECHNICAL FIELD
This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition.
BACKGROUND OF THE INVENTION
In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in
Compounds for enzyme inhibition
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
TECHNICAL FIELD
This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition.
BACKGROUND OF THE INVENTION
In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in
Compounds for enzyme inhibition
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
TECHNICAL FIELD
This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition.
BACKGROUND OF THE INVENTION
In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in
Compounds for enzyme inhibition
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
TECHNICAL FIELD
This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition.
BACKGROUND OF THE INVENTION
In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in
Compounds for proteasome enzyme inhibition
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
TECHNICAL FIELD
This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition.
BACKGROUND OF THE INVENTION
In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in
Compounds for enzyme inhibition
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
TECHNICAL FIELD
This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition.
BACKGROUND OF THE INVENTION
In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in
Compounds for enzyme inhibition
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
TECHNICAL FIELD
This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition.
BACKGROUND OF THE INVENTION
In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in
Compounds for enzyme inhibition
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
TECHNICAL FIELD
This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition.
BACKGROUND OF THE INVENTION
In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in
Compounds for enzyme inhibition
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
TECHNICAL FIELD
This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition.
BACKGROUND OF THE INVENTION
In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in
Enzyme inhibition
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
TECHNICAL FIELD
This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods deriving from enzyme inhibition.
BACKGROUND
In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in which proteins
Enzyme inhibition
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
TECHNICAL FIELD
This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods deriving from enzyme inhibition.
BACKGROUND
In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in which proteins
Самая поўная база дадзеных пра лекавыя травы, падтрыманая навукай
- Працуе на 55 мовах
- Лячэнне травой пры падтрымцы навукі
- Распазнаванне траў па малюнку
- Інтэрактыўная GPS-карта - пазначце травы па месцы (хутка)
- Чытайце навуковыя публікацыі, звязаныя з вашым пошукам
- Шукайце лекавыя зёлкі па іх уздзеянні
- Арганізуйце свае інтарэсы і будзьце ў курсе навінавых даследаванняў, клінічных выпрабаванняў і патэнтаў
Увядзіце сімптом альбо захворванне і прачытайце пра зёлкі, якія могуць дапамагчы, набярыце траву і паглядзіце хваробы і сімптомы, супраць якіх яна выкарыстоўваецца.
* Уся інфармацыя заснавана на апублікаваных навуковых даследаваннях
